Clinical trial
A Pilot Study of the Drug-eluting Coronary Spur StEnt as a Primary trEatment for In-stent Restenosis of the CORONARY Arteries (DEEPER CORONARY)
NCT06117150 is registered in ClinicalTrials.gov with ReFlow Medical, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study of the Drug-eluting Coronary Spur StEnt as a Primary trEatment for In-stent Restenosis of the CORONARY Arteries (DEEPER CORONARY)
- Lead sponsor
- ReFlow Medical, Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- June 12, 2024
- Completion date
- June 23, 2026
- Enrollment
- 9 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
in-stent restenosis